Paulson Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$551K Sell
4,584
-4,880
-52% -$563K 0.13% 69
2025
Q4
$996K Sell
9,464
-261
-3% -$24.5K 0.23% 53
2025
Q3
$816K Sell
9,725
-967
-9% -$79.6K 0.19% 59
2025
Q2
$846K Buy
10,692
+5,725
+115% +$455K 0.22% 53
2025
Q1
$446K Sell
4,967
-142
-3% -$13.3K 0.13% 78
2024
Q4
$508K Sell
5,109
-1,214
-19% -$125K 0.14% 72
2024
Q3
$718K Sell
6,323
-79
-1% -$9.39K 0.19% 58
2024
Q2
$793K Sell
6,402
-175
-3% -$22.5K 0.23% 54
2024
Q1
$868K Sell
6,577
-88
-1% -$10.8K 0.26% 47
2023
Q4
$727K Sell
6,665
-929
-12% -$96.4K 0.23% 50
2023
Q3
$782K Sell
7,594
-146
-2% -$15.7K 0.27% 51
2023
Q2
$893K Buy
7,740
+1,398
+22% +$159K 0.31% 46
2023
Q1
$675K Buy
6,342
+222
+4% +$24K 0.3% 32
2022
Q4
$679K Sell
6,120
-156
-2% -$15.9K 0.33% 31
2022
Q3
$541K Sell
6,276
-236
-4% -$21.1K 0.29% 29
2022
Q2
$594K Buy
6,512
+368
+6% +$32.6K 0.31% 29
2022
Q1
$504K Buy
6,144
+115
+2% +$9.07K 0.23% 38
2021
Q4
$462K Sell
6,029
-312
-5% -$24.9K 0.21% 47
2021
Q3
$476K Sell
6,341
-154
-2% -$11.7K 0.23% 55
2021
Q2
$505K Sell
6,495
-335
-5% -$24.9K 0.24% 52
2021
Q1
$500K Buy
6,830
+821
+14% +$60.6K 0.25% 51
2020
Q4
$469K Buy
6,009
+684
+13% +$52.3K 0.27% 48
2020
Q3
$421K Buy
5,325
+295
+6% +$23.1K 0.27% 52
2020
Q2
$371K Buy
5,030
+1,073
+27% +$80.8K 0.26% 58
2020
Q1
$310K Buy
3,957
+907
+30% +$71.3K 0.24% 64
2019
Q4
$265K Sell
3,050
-1,080
-26% -$88.7K 0.19% 84
2019
Q3
$332K Sell
4,130
-416
-9% -$33.3K 0.25% 74
2019
Q2
$356K Sell
4,546
-678
-13% -$51.9K 0.27% 73
2019
Q1
$415K Hold
5,224
0.31% 67
2018
Q4
$378K Buy
5,224
+854
+20% +$60.3K 0.31% 70
2018
Q3
$300K Sell
4,370
-43
-1% -$2.74K 0.27% 87
2018
Q2
$256K Buy
4,413
+33
+0.8% +$1.86K 0.25% 90
2018
Q1
$228K Buy
4,380
+184
+4% +$9.94K 0.23% 99
2017
Q4
$225K Buy
+4,196
New +$233K 0.2% 95

Other funds holding MRK

Paulson Wealth Management's MRK Position: Q1 2026 in Review

Paulson Wealth Management reduced its Merck (MRK) stake by 52% in Q1 2026, selling an estimated $563K and leaving 4,584 shares worth $551K. The position accounts for 0.13% of the portfolio, ranked #69.

Paulson Wealth Management first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $996K in Q4 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Paulson Wealth Management held 4,584 shares of Merck worth $551K as of Q1 2026.
  • Paulson Wealth Management sold 4,880 Merck shares in Q1 2026, an estimated $563K.
  • Merck made up 0.13% of Paulson Wealth Management's portfolio in Q1 2026, its #69 holding.
  • Paulson Wealth Management first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
  • Paulson Wealth Management's Merck position peaked at $996K in Q4 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Paulson Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.